| SARS-CoV-2–triggered neutrophil extracellular traps mediate COVID-19 pathology FP Veras, MC Pontelli, CM Silva, JE Toller-Kawahisa, M de Lima, ... Journal of Experimental Medicine 217 (12), e20201129, 2020 | 862 | 2020 |
| RETRACTED ARTICLE: Molecular characterization of LC3-associated phagocytosis reveals distinct roles for Rubicon, NOX2 and autophagy proteins J Martinez, RKS Malireddi, Q Lu, LD Cunha, S Pelletier, S Gingras, ... Nature cell biology 17 (7), 893-906, 2015 | 825 | 2015 |
| Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients TS Rodrigues, KSG de Sá, AY Ishimoto, A Becerra, S Oliveira, L Almeida, ... Journal of Experimental Medicine 218 (3), 2021 | 751 | 2021 |
| Gene-microbiota interactions contribute to the pathogenesis of inflammatory bowel disease H Chu, A Khosravi, IP Kusumawardhani, AHK Kwon, AC Vasconcelos, ... Science 352 (6289), 1116-1120, 2016 | 601 | 2016 |
| Inflammasome-derived IL-1β production induces nitric oxide–mediated resistance to Leishmania DS Lima-Junior, DL Costa, V Carregaro, LD Cunha, ALN Silva, ... Nature medicine 19 (7), 909-915, 2013 | 400 | 2013 |
| LC3-associated phagocytosis in myeloid cells promotes tumor immune tolerance LD Cunha, M Yang, R Carter, C Guy, L Harris, JC Crawford, G Quarato, ... Cell 175 (2), 429-441. e16, 2018 | 284 | 2018 |
| NLRP3 inflammasome–mediated neutrophil recruitment and hypernociception depend on leukotriene B4 in a murine model of gout FA Amaral, VV Costa, LD Tavares, D Sachs, FM Coelho, CT Fagundes, ... Arthritis & Rheumatism 64 (2), 474-484, 2012 | 256 | 2012 |
| LC3-associated phagocytosis and inflammation BL Heckmann, E Boada-Romero, LD Cunha, J Magne, DR Green Journal of molecular biology 429 (23), 3561-3576, 2017 | 240 | 2017 |
| Beneficial effects of colchicine for moderate to severe COVID-19: a randomised, double-blinded, placebo-controlled clinical trial MI Lopes, LP Bonjorno, MC Giannini, NB Amaral, PI Menezes, SM Dib, ... RMD open 7 (1), e001455, 2021 | 229 | 2021 |
| Cutting edge: nucleotide-binding oligomerization domain 1-dependent responses account for murine resistance against Trypanosoma cruzi infection GK Silva, FRS Gutierrez, PMM Guedes, CV Horta, LD Cunha, TWP Mineo, ... The journal of immunology 184 (3), 1148-1152, 2010 | 149 | 2010 |
| Inhibition of caspase-1 or gasdermin-D enable caspase-8 activation in the Naip5/NLRC4/ASC inflammasome DPA Mascarenhas, DM Cerqueira, MSF Pereira, FVS Castanheira, ... PLoS pathogens 13 (8), e1006502, 2017 | 134 | 2017 |
| Critical role of ASC inflammasomes and bacterial type IV secretion system in caspase-1 activation and host innate resistance to Brucella abortus infection MTR Gomes, PC Campos, FS Oliveira, PP Corsetti, KR Bortoluci, ... The Journal of Immunology 190 (7), 3629-3638, 2013 | 125 | 2013 |
| Inhibition of inflammasome activation by Coxiella burnetii type IV secretion system effector IcaA LD Cunha, JM Ribeiro, TD Fernandes, LM Massis, CA Khoo, JH Moffatt, ... Nature communications 6 (1), 10205, 2015 | 99 | 2015 |
| Subversion of inflammasome activation and pyroptosis by pathogenic bacteria LD Cunha, DS Zamboni Frontiers in cellular and infection microbiology 3, 76, 2013 | 97 | 2013 |
| Caspase-1 but not caspase-11 is required for NLRC4-mediated pyroptosis and restriction of infection by flagellated Legionella species in mouse macrophages and in vivo DM Cerqueira, MSF Pereira, ALN Silva, LD Cunha, DS Zamboni The Journal of Immunology 195 (5), 2303-2311, 2015 | 86 | 2015 |
| AIM2 engages active but unprocessed caspase-1 to induce noncanonical activation of the NLRP3 inflammasome LD Cunha, ALN Silva, JM Ribeiro, DPA Mascarenhas, GFS Quirino, ... Cell reports 20 (4), 794-805, 2017 | 76 | 2017 |
| A novel pathway for inducible nitric-oxide synthase activation through inflammasomes CL Buzzo, JC Campopiano, LM Massis, SL Lage, AA Cassado, ... Journal of biological chemistry 285 (42), 32087-32095, 2010 | 62 | 2010 |
| Gasdermin-D activation by SARS-CoV-2 triggers NET and mediate COVID-19 immunopathology CMS Silva, CWS Wanderley, FP Veras, AV Gonçalves, MHF Lima, ... Critical Care 26 (1), 206, 2022 | 44 | 2022 |
| Beneficial effects of colchicine for moderate to severe COVID-19: an interim analysis of a randomized, double-blinded, placebo controlled clinical trial MIF Lopes, LP Bonjorno, MC Giannini, NB Amaral, MN Benatti, UC Rezek, ... MedRxiv, 2020.08. 06.20169573, 2020 | 42 | 2020 |
| Efferocytosis of SARS-CoV-2-infected dying cells impairs macrophage anti-inflammatory functions and clearance of apoptotic cells ACG Salina, D Dos-Santos, TS Rodrigues, M Fortes-Rocha, ... Elife 11, e74443, 2022 | 35 | 2022 |
